PF-05175157

· Pfizer

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for PF-05175157, covering 2011-10-12 to 2017-02-16. Get the full timeline:

Most recent: Clinical Trial Update: A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus [Phase 2]